NO823765L - Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.

Info

Publication number
NO823765L
NO823765L NO823765A NO823765A NO823765L NO 823765 L NO823765 L NO 823765L NO 823765 A NO823765 A NO 823765A NO 823765 A NO823765 A NO 823765A NO 823765 L NO823765 L NO 823765L
Authority
NO
Norway
Prior art keywords
formula
compound
carbon atoms
given above
hydrogen
Prior art date
Application number
NO823765A
Other languages
English (en)
Norwegian (no)
Inventor
Rodney Brian Hargreaves
Bernhard Joseph Mcloughlin
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of NO823765L publication Critical patent/NO823765L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO823765A 1981-11-12 1982-11-11 Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser. NO823765L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8134176 1981-11-12

Publications (1)

Publication Number Publication Date
NO823765L true NO823765L (no) 1983-05-13

Family

ID=10525837

Family Applications (1)

Application Number Title Priority Date Filing Date
NO823765A NO823765L (no) 1981-11-12 1982-11-11 Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.

Country Status (12)

Country Link
US (1) US4493835A (enExample)
EP (1) EP0086301A1 (enExample)
JP (1) JPS58131973A (enExample)
AU (1) AU9000682A (enExample)
DK (1) DK487082A (enExample)
ES (1) ES517333A0 (enExample)
FI (1) FI823895A7 (enExample)
GR (1) GR77782B (enExample)
IL (1) IL67098A0 (enExample)
NO (1) NO823765L (enExample)
PT (1) PT75828A (enExample)
ZA (1) ZA827641B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3172252D1 (en) * 1980-11-14 1985-10-17 Ici Plc Heterocyclic compounds
US4657906A (en) * 1982-06-05 1987-04-14 Smith Kline & French Laboratories Ltd. Heterocyclic compounds having inotropic activity
GB8310435D0 (en) * 1983-04-18 1983-05-25 Fujisawa Pharmaceutical Co Triazine derivatives
GB8328907D0 (en) * 1983-10-28 1983-11-30 Smith Kline French Lab Chemical compounds
GB8332313D0 (en) * 1983-12-02 1984-01-11 Smith Kline French Lab Chemical compounds
US4508718A (en) * 1984-01-16 1985-04-02 Warner-Lambert Company Cardiotonic and antihypertensive oxadiazinone compounds
US4898862A (en) * 1986-03-20 1990-02-06 Sankyo Company Limited 1,2,4-triazinone derivatives, their preparation and use
US5185332A (en) * 1989-02-11 1993-02-09 Orion-Yhtyma Oy Thiadiazines and pharmaceutical compositions thereof as well as method of use
US11897867B2 (en) 2017-08-04 2024-02-13 Bayer Aktiengesellschaft 6-phenyl-4,5-dihydropyridazin-3(2H)-one derivatives as PDE3A and PDE3B inhibitors for treating cancer
JOP20200024A1 (ar) 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
AU2020215088A1 (en) * 2019-02-01 2021-07-22 Bayer Aktiengesellschaft 1,2,4-triazin-3(2H)-one compounds for the treatment of hyperproliferative diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3377345A (en) * 1966-09-23 1968-04-09 Dow Chemical Co Substituted 3, 4, 5, 6-tetrahydro-2h-1, 3, 4-oxadiazin-2-one compounds and method ofpreparation thereof
FR8169M (enExample) * 1967-05-17 1970-08-31
US3946010A (en) * 1975-04-09 1976-03-23 E. R. Squibb & Sons, Inc. 3-Phenyl-2,5-dihydro-as-triazin-6 (1H)-ones
US4097671A (en) * 1975-08-28 1978-06-27 General Electric Company Dihydrooxadiazinones and method for making
US4097425A (en) * 1975-08-28 1978-06-27 General Electric Company Thermoplastic formable blends, a foaming method and products made thereby
US4105848A (en) * 1976-12-27 1978-08-08 General Electric Company Process for the production of dihydrooxadiazinone compounds
DE3172252D1 (en) * 1980-11-14 1985-10-17 Ici Plc Heterocyclic compounds

Also Published As

Publication number Publication date
FI823895L (fi) 1983-05-13
FI823895A7 (fi) 1983-05-13
PT75828A (en) 1982-12-01
US4493835A (en) 1985-01-15
FI823895A0 (fi) 1982-11-12
DK487082A (da) 1983-05-13
ES8404340A1 (es) 1984-04-16
GR77782B (enExample) 1984-09-25
EP0086301A1 (en) 1983-08-24
AU9000682A (en) 1983-05-19
JPS58131973A (ja) 1983-08-06
ES517333A0 (es) 1984-04-16
ZA827641B (en) 1983-09-28
IL67098A0 (en) 1983-02-23

Similar Documents

Publication Publication Date Title
US4503054A (en) 6-Aryl-1,2,4-triazin-6-ones which possess cardiotonic properties
CA1199028A (en) Derivatives of phenyl-: -thiadiazinone, -oxadiazinone and -triazinone
CA1199027A (en) Heterocyclic derivatives of pyridazinone, thiadiazinone, oxadiazinone and triazinone
US5366992A (en) Benzoic acid substituted derivatives having cardiovascular activity
PL194758B1 (pl) Zastosowanie podstawionych 3,5-difenylo-1,2,4-triazoli, preparat zawierający podstawione 3,5-difenylo-1,2,4-triazole, nowe podstawione 3,5-difenylo-1,2,4-triazole preparat je zawierający, ich zastosowanie oraz sposób wytwarzania nowych podstawionych 3,5-difenylo-1,2,4-triazoli
NO823765L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser.
US4489074A (en) 1,3,4-Thiadiazin-2-ones
CS274405B2 (en) Method of 4-cyanopyridazines preparation
US4087526A (en) (3-Amino-5-substituted-6-fluoropyrazinoyl or pyrazamido)-guanidines and their derivatives bearing substituents on the guanidino nitrogens
HU213212B (en) Process for producing acid additional salts of 4-amino-2-ureidopyrimidine-5-carboxylic acid amide derivatives and pharmaceutical compositions comprising the same
SK281387B6 (sk) Deriváty kyseliny hydroxímovej, farmaceutický prostriedok, ktorý ich obsahuje, spôsob ich prípravy a medziprodukty na ich prípravu
IE42759B1 (en) Hydroxypolyhaloisopropyl substituted ureido-compounds
US4454132A (en) Pharmaceutical compositions of novel substituted pyrazinyl-1,2,4-oxadiazoles useful in the treatment of edema and hypertension
FR2460294A1 (fr) Nouveaux oxime-ethers, leur procede de preparation et compositions pharmaceutiques les contenant
KR840002309B1 (ko) 구아니딘 화합물의 제조방법
WO1981000567A1 (en) Sydnone imines
AU662939B2 (en) Nitroxyalkylamide derivatives
US3946010A (en) 3-Phenyl-2,5-dihydro-as-triazin-6 (1H)-ones
US4041072A (en) Acetamidoxime compounds
US5604226A (en) Pyridazinone derivatives, processes for production thereof and use thereof
US4965259A (en) Dioxazocine derivatives compositions and methods containing them having antidepressive, spasmolytic, anticonvulsive, and antiarrhythmic properties
SK166495A3 (en) Pharmacologically effective enantiomers, preparation method threof, intermediate products of this method and use
HU199792B (en) Process for producing new indolecarboxamide derivatives and pharmaceutical compositions comprising such compounds
US4151168A (en) 5-Phenyl-2-oxazole carboximidamides as antidepressants
CA1113090A (en) Preparation of novel 1,4-cycloalkano-oxazepines